Drug Information

Drug General Information
Drug ID
D0Z1OS
Former ID
DNCL002833
Drug Name
ARI-2243
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [548767]
Company
Arisaph Pharmaceuticals
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Modulator [544150]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 548767Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028500)
Ref 544150Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors. Mayo Clin Proc. 2010 December; 85(12 Suppl): S27-S37.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.